Opaleye Management Inc. Fibrogen Inc Transaction History

Opaleye Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $2.73 Million - $5.24 Million	-147,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $40,470 - $45,500	1,000 Added 0.68%	147,000 $6.05 Million
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $138,320 - $192,240	-4,000 Reduced 2.67%	146,000 $6.26 Million
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $1.76 Million - $2.78 Million	-50,000 Reduced 25.0%	150,000 $6.78 Million
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $9.01 Million - $10.8 Million	-160,000 Reduced 44.44%	200,000 $12.2 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $12 Million - $19.4 Million	360,000	360,000 $19.4 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $46.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.